InsiderClue
Insiders · Profile

Meeker David P

President and CEO at RHYTHM PHARMACEUTICALS · Director at Trevi Therapeutics. Filing since 10 Oct 2017. CIK 0001385155

RYTM RHYTHM PHARMACEUTICALS, INC. President and CEO · 8 trades TRVI Trevi Therapeutics, Inc. Director · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
RYTM RHYTHM PHARMACEUTICALS, INC.
14 Sep 2026
President and CEO
Sold on a plan
50,000
$5.13M
17.3%
RYTM RHYTHM PHARMACEUTICALS, INC.
3 Jun 2025
President and CEO
Sold on a plan
43,620
$2.84M
17.8%
RYTM RHYTHM PHARMACEUTICALS, INC.
19 Feb 2025
President and CEO
Sold on a plan
9,896
$566.25K
4.7%
RYTM RHYTHM PHARMACEUTICALS, INC.
4 Feb 2025
President and CEO
Sold at will
4,278
$254.24K
2.2%
TRVI Trevi Therapeutics, Inc.
27 Aug 2024
Director
Sold at will
4,555
$13.35K
1.3%
RYTM RHYTHM PHARMACEUTICALS, INC.
19 Mar 2024
President and CEO
Sold at will
45,494
$1.78M
20.7%
RYTM RHYTHM PHARMACEUTICALS, INC.
1 Feb 2024
President and CEO
Sold at will
4,361
$196.51K
3.5%
RYTM RHYTHM PHARMACEUTICALS, INC.
30 Mar 2021
President and CEO
Bought
10,000
$201.71K
9.9%
TRVI Trevi Therapeutics, Inc.
9 May 2019
Director
Bought
11,250
$112.50K
3.3%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
Director
Bought
25,000
$425.00K
32.8%
10 decisions on file.